“…Possible diseases of interest that affect the choroid include noninfectious uveitis, dry forms of AMD, choroideremia, uveal melanoma, and central serous chorioretinopathy. The therapeutic effects of corticosteroids[33, 45, 59, 73, 90], small molecules [29, 36, 46, 47, 69, 72], monoclonal antibodies[33, 62], and cells[35, 63] injected into the SCS have been tested in preclinical and clinical trials. Indeed, phase I/II clinical trial results have been promising[73].…”